Therefore, given the lack of studies evaluating the immunohistochemical expression of P4HB and SOX4 in PAC and their relationship with clinicopathological parameters, we designed this research to investigate P4HB and SOX4 expression in prostatic carcinoma, their possible roles and clinical significance and to test their hypothesized relationship. This evidence concerns the gene SOX4 and prostate carcinoma.